. "Feasibility Study of Docetaxel and Cyclophosphamide Six-Cycle Therapy as Adjuvant Chemotherapy for Japanese Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Patients". Asian Pacific Journal of Cancer Prevention, 14, 8, 2013, 4835-4838.